Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis

Cancer

Volumn 121, Issue 23, 2015, Pages 4222-4230

  Nanda, Ronica H ^a,b   Liu, Yuan ^b,c   Gillespie, Theresa W ^b   Mikell, John L ^a,b   Ramalingam, Suresh S ^a,b   Fernandez, Felix G ^a,b   Curran, Walter J ^a,b   Lipscomb, Joseph ^b,c   Higgins, Kristin A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

elderly; non small cell lung cancer; observation; radiosurgery; stereotactic body radiation therapy

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STEREOTACTIC BODY RADIATION THERAPY; VERY ELDERLY; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; COMPARATIVE STUDY; DISEASE MANAGEMENT; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOSURGERY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DISEASE MANAGEMENT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84948578965     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29640     Document Type: Article

References (32)

1. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Lung Cancer (version 2.2015). Available at: http://www.nccn.org/professionals/physician-gls/pdf/nscl.pdf. Accessed December 17, 2014.
2. McGarry RC, Song G, des Rosiers P, et al. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121:1155-1158.
3. Jeremic B, Classen J, Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;54:119-130.
4. Fang LC, Komaki R, Allen P, et al. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with 2-dimensional versus 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:108-116.
5. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 1998;40:149-154.
6. Chadha AS, Ganti AK, Sohi JS, et al. Survival in untreated early stage non-small cell lung cancer. Anticancer Res. 2005;25:3517-3520.
7. Palma D, Visser O, Lagerwaard FJ, et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol. 2011;101:240-244.
8. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615-622.
9. Landreneau RJ, Normolle DP, Christie NA, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol. 2014;32:2449-2455.
10. Fernando HC, Landreneau RJ, Mandrekar SJ, et al. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer. J Clin Oncol. 2014;32:2456-2462.
11. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303: 1070-1076.
12. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84:1060-1070.
13. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small cell lung cancer. J Clin Oncol. 2010;28:928-935.
14. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010;140:377-386.
15. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of 2 randomised trials. Lancet Oncol. 2015;16: 630-637.
16. Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-Analysis [serial online]. Syst Rev. 2013;2:10.
17. Cannon NA, Iyengar P, Choy H, et al. Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study [serial online]. BMC Cancer. 2014;14:971.
18. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. New York: Springer; 2010.
19. Nickleach D, Liu Y, Shrewsberry A, et al. SAS Macros to Conduct Common Biostatistical Analyses and Generate Reports [abstract PO-05]. Proceeding of the Southeast SAS User Group (SESUG) 2013. Available at: http://analytics.ncsu.edu/sesug/2013/po-05.pdf. Accessed December 9, 2014.
20. Giobbie-Hurder A, Gelber RD, Regan MM. Challenges of guarantee-Dime bias. J Clin Oncol. 2013;31:2963-2969.
21. Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes. 2011;4:363-371.
22. Snapinn SM, Jiang Q, Iglewicz B. Illustrating the impact of a timevarying covariate with an extended Kaplan-Meier estimator. Am Stat. 2005;59:301-307.
23. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132: 193-199.
24. Liu T, Liu H, Li Y. Early lung cancer in the elderly: sublobar resection provides equivalent long-Derm survival in comparison with lobectomy. Contemp Oncol. 2014;18:111-115.
25. World Health Organization. Prevalence of tobacco use among adults and adolescents. Geneva, Switzerland: World Health Organization; 2015. Available at: http://gamapserver.who.int/gho/interactive-charts/tobacco/use/atlas.html. Accessed June 15, 2015.
26. Squires DA. The US Health System in Perspective: A Comparison of Twelve Industrialized Nations. July 2011. Available at: http://www.commonwealthfund.org/-/media/files/publications/issue%20-brief/2011/jul/1532-squires-us-hlt-sys-comparison-12-nations-intl-brief-v2.pdf. Accessed June 1, 2015.
27. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, et al. Stage I nonsmall cell lung cancer in patients aged-75 years: outcomes after stereotactic radiotherapy. Cancer. 2010;116:406-414.
28. Robinson CG, Patel A, Bradley JD, et al. Survival following stereotactic body radiation therapy or conventionally fractionated radiation for definitive non-operative treatment of stage I non-small cell lung cancer: a review of the National Cancer Data Base. J Clin Oncol. 2015;33(15 suppl). Abstract 7513.
29. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-Derm follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382-2387.
30. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (version 1.2015). Available at: http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf. Accessed November 1, 2014.
31. Stanic S, Paulus R, Timmerman RD, et al. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol Biol Phys. 2014;88:1092-1099.
32. Prendergast BM, Dobelbower MC, Bonner JA, et al. Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute [serial online]. Radiat Oncol. 2013;8:273.